Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$10.75 - $12.29 $172,666 - $197,401
16,062 New
16,062 $182,000
Q4 2022

Feb 14, 2023

BUY
$12.08 - $13.81 $170,001 - $194,348
14,073 New
14,073 $178,000
Q1 2022

May 16, 2022

SELL
$13.33 - $19.98 $259,121 - $388,391
-19,439 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$19.42 - $22.42 $128,754 - $148,644
-6,630 Reduced 25.43%
19,439 $385,000
Q3 2021

Nov 15, 2021

BUY
$21.89 - $25.16 $227,546 - $261,538
10,395 Added 66.32%
26,069 $580,000
Q2 2021

Aug 16, 2021

BUY
$19.75 - $24.89 $309,561 - $390,125
15,674 New
15,674 $390,000
Q1 2021

May 17, 2021

SELL
$21.08 - $27.89 $452,587 - $598,798
-21,470 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$17.79 - $25.99 $381,951 - $558,005
21,470 New
21,470 $509,000
Q3 2020

Nov 16, 2020

SELL
$16.32 - $19.06 $519,416 - $606,622
-31,827 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$12.01 - $18.17 $382,242 - $578,296
31,827 New
31,827 $559,000

Others Institutions Holding GNOM

About GLOBAL X FDS GENOMICS & BIOTEC


  • Ticker GNOM
  • Sector ETFs
  • Industry ETFs
More about GNOM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.